Atlas Trials

Effect of Extended Dose Intervals on the Immune Response to Oral Cholera Vaccine

Clinical trial NCT03373669 · COMPLETED

Trial details

NCT number
NCT03373669
Sponsor
Johns Hopkins Bloomberg School of Public Health
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
CholeraVibrio Cholerae Infection
Start date
2017-11-16
Primary completion
2019-10-16
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.